| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Wealth Building > Will You Outlive Your Money? |
|
Write You - Will You Outlive Your Money?
The number of retirees is set to double over the next 30 years according to the U.S. Census Bureau. In 2008, the leading edge of the baby boom generation – those born between 1946 and 1964 – will turn 62. By the year 2050, According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product over one million Americans are projected to be 100 years of age or older. For the 78 million Americans who make up this generation, retirement may represent the longest stage of their life. Along with a much longer life, ho ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ever, comes more complex and more expensive financial challenges. Proper planning and preparation is critical for meeting the challenges and uncertainties that lie ahead as you approach retirement and during your retirement lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. years to protect against the potential risk of outliving your money. When people retire, they want their retirement funds to last for the rest of their life. How much you need to finance your retirement depends on how well here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ou want to live and the expected length of your retirement life. Do you want to maintain or increase your standard of living? Do you want to start a new business, provide financial help to family members or engage in a new h d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro bby or activity? How much you need to accumulate depends on the lifestyle you envision. The shift away from defined benefit plans to defined contribution plans is a trend that has revolutionized retirement planning by placi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng more of the responsibility for saving on the individual. Since fewer retirees in the future can expect to receive a steady stream of income from employer provided defined benefit plans, individuals will have to rely more o easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi their own resources for a much higher percentage of their retirement income. Now more than ever, people are faced with having to make serious decisions about how to manage their company retirement plan, how much to contribu nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e, how to invest their money and what to do with their vested balance after they retire. They need to have a plan based on clear and accurate information to help them make decisions about when to retire, how long they can ex and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ pect to live in retirement, how much they need to accumulate and how to manage their funds throughout their retirement years. Many people depend on a fixed income stream during retirement. However, in an inflationary enviro ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ment, a fixed income stream will not allow one to maintain a constant standard of living. A more appropriate means of providing an income stream throughout the retirement years is to have your income increase annually with i ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a flation. For example, to receive the equivalent of $150,000 in today’s dollars at the beginning of each year increasing at the rate of 3% for thirty-five years, you would need an estimated target portfolio of over $2,620,000 dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod earning an average annual after-tax return of 8%. Decisions about when to retire, how long you can expect to live in retirement and how much you need to accumulate are complicated by an ever changing set of circumstances. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ncertain knowledge of investment returns, length of life in retirement, and rising expenditures make assumptions about the future less reliable. An extended market decline soon after retirement could jeopardize the sustainab tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen lity of withdrawals over the life of the retirement period. This is a significant risk in retirement, which can have a tremendous impact on retirement security. When planning for retirement, the challenge is to assure that y t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ou never outlive your money. How you configure your retirement accumulations using the most appropriate asset allocation strategy is one of the most important factors that determines both the risk and return of your portfoli ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust . During the distribution phase, the sustainability of your investment portfolio depends largely on the stability of the withdrawal rate. This is the rate of portfolio liquidation, expressed as a percentage. Meeting financi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products l obligations through an investment-based approach is only one part of the process. If the withdrawal rate increases over the years, more of the portfolio will be liquidated each year increasing the possibility that the port . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de folio will be depleted much sooner the expected. Combining a diversified allocation strategy with a guaranteed income stream increases the likelihood that the retirement funds will provide an income for life. If you are co elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip mitted to the proper management of your retirement funds today, you will be in the best possible position to achieve your goal of financial independence and freedom for tomorrow. Copyright © 2006 William E. Griffith, Jr. CFP tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Dog Business is More Than Doggie Poo Uniting a Franchise System in a Common Cause The Best Tips On Buying properties In The Dominican Republic
|